GlassScriptPhysician profile
Sandeep A Patel
NPI 1861490534
$7,282.60
in general payments reported to CMS, 2019-2025
36 companies · $1,146 in 2025
The $1,146 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $667 · 2020: $756 · 2021: $740 · 2022: $800 · 2023: $1,403 · 2024: $1,771 · 2025: $1,146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,320.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,320.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $984.64 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $847.38 | 2019-2024 | Xarelto |
| Abiomed | $549.97 | 2019-2025 | Impella |
| Astrazeneca Pharmaceuticals LP | $528.34 | 2019-2024 | Lokelma, Farxiga |
| Merck Sharp & Dohme LLC | $447.12 | 2021-2025 | Verquvo |
| Medtronic, INC. | $378.08 | 2023-2025 | Corevalve Evolut R, Symplicity G3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $336.40 | 2020-2025 | Jardiance |
| Amgen INC. | $317.72 | 2019-2024 | Repatha |
| Ancora Heart, INC. | $272.65 | 2021-2023 | Accucinch |
| Alnylam Pharmaceuticals INC. | $256.76 | 2023-2025 | Onpattro |
| E.R. Squibb & Sons, L.L.C. | $240.18 | 2019-2025 | Camzyos, Eliquis |
| Abbott Laboratories | $225.54 | 2022-2025 | Cardiomems |
| Angiodynamics, INC. | $216.08 | 2023 | Auryon Laser System 100-120 Vac |
| Pfizer INC. | $202.93 | 2020-2025 | |
| Cardiac Dimensions, INC. | $178.90 | 2024 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $166.41 | 2024 | Enhertu |
| Kestra Medical Technology Services, INC. | $124.53 | 2022-2024 | Assure Wcd |
| Shockwave Medical, INC | $123.92 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $117.50 | 2020-2023 | |
| Amarin Pharma, INC. | $99.89 | 2019-2022 | |
| Esperion Therapeutics, INC. | $90.18 | 2020-2025 | Nexletol |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $86.17 | 2019-2024 | Lifevest |
| Novo Nordisk INC | $76.12 | 2023-2025 | Ozempic, Wegovy, Rybelsus |
| Kowa Pharmaceuticals America, INC. | $68.91 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $64.36 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $53.74 | 2021-2024 | Evkeeza |
| Sanofi-Aventis U.S. LLC | $36.81 | 2019-2023 | |
| Lexicon Pharmaceuticals, INC. | $35.95 | 2024 | |
| Scpharmaceuticals INC. | $33.07 | 2024-2025 | |
| Mannkind Corporation | $25.49 | 2025 | |
| Itamar Medical INC | $22.35 | 2023 | Watchpatone |
| Gilead Sciences, INC. | $16.41 | 2019 | |
| Cook Medical LLC | $15.68 | 2023 | Zilver Vena |
| Medtronic Vascular, INC. | $15.47 | 2019 | |
| Vifor Pharma, INC. | $13.48 | 2021 | |
| Atricure, INC. | $13.47 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandeep Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.